Discover
FBLG
FibroBiologics, Inc. Common Stock
0.98
33 x 1.04
2 x 1.13
bid
ask
-
0.04
4.29%
1 @ 04:00 PM
1.04 +0.06 (6.54%)
| Ytd | -78.31% | |
| 1y | -90.86% |
0.97
day range
1.06
0.63
52 week range
12.42
| Open | 1.02 | Prev Close | 1.02 | Low | 0.97 | High | 1.06 | Mkt Cap | 2.05M |
| Vol | 162.80K | Avg Vol | 189.09K | EPS | -2.56 | P/E | -0.38 | Forward P/E | -5.83 |
| Beta | 1.20 | Short Ratio | 13.56 | Inst. Own | 15.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 0.88 | 200-d Avg | 4.02 | 1yr Est | 12.75 |
| Income Statement | |||
| Operating Expenses | 4.03M | ||
| Research and Development Expense | 1.66M | ||
| Selling, General and Administrative Expense | 2.38M | ||
| Operating Income | -4.03M | ||
| Interest Expense | 7.00K | ||
| Net Income | -4.12M | ||
| Net Income Common Stock | -4.12M | ||
| Net Income Common Stock (USD) | -4.12M | ||
| Consolidated Income | -4.12M | ||
| Earnings per Basic Share | -0.66 | ||
| Earnings per Basic Share (USD) | -0.66 | ||
| Earnings per Diluted Share | -0.66 | ||
| Earning Before Interest & Taxes (EBIT) | -4.11M | ||
| Earning Before Interest & Taxes (USD) | -4.11M | ||
| Weighted Average Shares | 6.27M | ||
| Weighted Average Shares Diluted | 6.27M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.52M | ||
| Cash and Equivalents (USD) | 3.52M | ||
| Current Assets | 5.85M | ||
| Property, Plant & Equipment Net | 2.03M | ||
| Total Assets | 7.93M | ||
| Debt Current | 382.00K | ||
| Total Debt | 1.46M | ||
| Current Liabilities | 2.21M | ||
| Debt Non-Current | 1.08M | ||
| Total Liabilities | 3.29M | ||
| Accumulated Retained Earnings (Deficit) | -63.28M | ||
| Shareholders Equity | 4.64M | ||
| Shareholders Equity (USD) | 4.64M | ||
| Assets Non-Current | 2.08M | ||
| Total Debt (USD) | 1.46M | ||
| Liabilities Non-Current | 1.08M | ||
| Trade and Non-Trade Payables | 1.82M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 161.00K | ||
| Net Cash Flow from Financing | 5.32M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.03M | ||
| Issuance (Purchase) of Equity Shares | 5.45M | ||
| Issuance (Repayment) of Debt Securities | -122.00K | ||
| Net Cash Flow from Operations | -3.29M | ||
| Share Based Compensation | 707.00K | ||